Jun Deng

Jun is a strategist with experience, from seed to growth, in Life Sciences and Healthcare.
As the first investment partner in Joyance, Jun established the healthcare investment strategies and has led over forty investments, including two exits, Volumetric Bio (acquired by 3D System) and Osmosis (acquired by Reed/Elsevier).
She served board roles at Nymbl Science, BioEclipse Therapeutics, and Pop Up Health.
Jun was a venture mentor at Singularity University and is currently a mentor at Endless Frontier Labs, New York University-associated accelerator program.
She is a strategic investor at HealthTech Capital.
in addition to her VC career, Jun has over seven years of scientific research experience.
Jun holds a Ph.D.
in Molecular Physiology from the University of California, Los Angeles.